Article Text
Treatment
Review: regular inhaled long acting β2 agonists are associated with better outcomes than short acting β2 agonists in adults and children with chronic asthma
Statistics from Altmetric.com
Footnotes
Source of funding: Commonwealth Department of Health and Aged.
For correspondence: Professor E H Walters, Clinical School, University of Tasmania, Hobart, Tasmania, Australia.Haydn.Walters{at}utas.edu.au